NEW YORK (GenomeWeb News) – Response Genetics today announced an agreement with managed healthcare firm MultiPlan to provide its members with access to Response's molecular diagnostic tests.

MultiPlan has about 67 million consumers accessing its provider network products, and it contracts with more than 900,000 healthcare providers across the US, Response said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.